Drug updated on 11/16/2023
| Dosage Form | Tablet (oral: 60 mg, 100 mg, 150 mg) |
| Drug Class | Tetracycline class antibacterials |
| Ongoing and Completed Studies | ClinicalTrials.gov |
Indication
- To treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients ≥ 9 years of age.
Product Monograph / Prescribing Information
| Document Title | Year | Source |
|---|---|---|
| Seysara (sarecycline) Prescribing Information. | 2021 | Almirall LLC, Malvern, PA |
Systematic Reviews / Meta-Analyses
| Document Title | Year | Source |
|---|---|---|
| Oral tetracyclines and acne: a systematic review for dermatologists. | 2020 | Journal of Drugs in Dermatology |